Clinical Trials Directory

Trials / Terminated

TerminatedNCT03867006

Optimization of the Preservation of Muscle Mass and / or Its Recovery by a Protein-energy Chrononutrition Approach Dissociated From Meals

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Muscle wasting has a multifactorial origin, including decreased physical activity, malnutrition, loss of post-incident muscle recovery abilities, and decreased ability to regenerate muscle. Among the strategies tested to improve the production of proteins and thus muscle is the supplementation of whey proteins. However this strategy does not seem sufficient and optimal to avoid muscle wasting and it must be complemented by a complementary action. Muscle protein degradation also occurs during the nocturnal fasting periods to provide amino acids for energy purposes and to produce glucose, essential for vital organs. The preservation of the benefit of whey intake during meals could therefore be optimized by reducing the use of muscle proteins for energy purposes during the night.

Detailed description

In this study, three arms will be studied for 3 months: 1 control group, 1 group with whey supplementation at lunch, and 1 group with whey supplementation at lunch and an energy bolus before bedtime. Actions include weight and body composition monitoring, nutritional status and muscle function, as well as mechanistic.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProteinIn addition to their normal meal, patients will eat 30g of whey protein every lunch during 90 days.
DIETARY_SUPPLEMENTProtein and CarbohydrateIn addition to their normal meal, patients will eat 30g of whey protein every lunch during 90 days and eat 60g of carbohydrates 2h after every diner during 90 days.

Timeline

Start date
2019-02-08
Primary completion
2022-10-31
Completion
2022-10-31
First posted
2019-03-07
Last updated
2023-04-18

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03867006. Inclusion in this directory is not an endorsement.